Traditional cooling systems for buildings use refrigerants and electricity, which contribute to the atmospheric greenhouse ...
PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.
PDS Biotechnology (PDSB) reaffirmed the Company’s guidance of initiating its VERSATILE-003 Phase 3 clinical trial of Versamune HPV plus ...
3d
Hosted on MSNPSE closes another PDS share purchase dealThe Philippine Stock Exchange Inc. (PSE) has closed another share purchase deal with one of the shareholders of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results